REVILAB PEPTIDE SL 06 (2023.)
Food supplement registered in Latvia
Register snapshot dated 2 May 2025. It does not establish the current status of the product.
- Number published by PVD
- 0001158/2023
- Type
- Food supplement
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- NPCRIZ Europe SIA
- Manufacturer
- SIA "HBO "VITA""
- Origin
- Latvija
- Register snapshot
- 2 May 2025
- Recommended daily intake (Latvian text)
- 20 pilieni
- Published pack size
- 10 ml
- Published packaging
- 10 ml
This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
The foreign register category does not determine the regulatory category of the product in France.
Published composition
| Published name | Published text and quantity | Recognised ingredient | Role or context |
|---|---|---|---|
| Ārstniecības kumelīte | plants ; Ārstniecības kumelīte ; Chamomille Recutita ; ekstrakts ; 24 ; mg | Not recognised | Role not identified |
| Apelsīns | plants ; Apelsīns ; Citrus sinensis ; ēteriskā eļļa ; 2,4 ; mg | citrus sinensis | Plant |
| Lakrica | plants ; Lakrica ; Glycyrrhiza glabra ; ekstrakts ; 2,4 ; mg | glycyrrhiza glabra | Plant |
| Piparmētra | plants ; Piparmētra ; Mentha piperita ; ekstrakts ; 2,4 ; mg | mentha piperita | Plant |
| Krustnagliņa | plants ; Krustnagliņa ; Syzygium aromaticum ; ēteriskā eļļa ; 0,12 ; mg | syzygium aromaticum | Plant |
| Propolisa sausais ekstrakts, 4:1 | otherNutrients ; Propolisa sausais ekstrakts, 4:1 ; 2,4 ; mg | Not recognised | Role not identified |
| Dihidrokvercetīns no Daurijas lapegles (Larix gmelinii) koksnes | otherNutrients ; Dihidrokvercetīns no Daurijas lapegles (Larix gmelinii) koksnes ; 1,2 ; mg | Not recognised | Role not identified |
| Peptīdu komplekss AA-15, kas satur aminoskābes (L-glutamīnskābi, L-asparagīnskābi un L-glicīnu) | otherNutrients ; Peptīdu komplekss AA-15, kas satur aminoskābes (L-glutamīnskābi, L-asparagīnskābi un L-glicīnu) ; 0,3 ; mg | Not recognised | Role not identified |
| Peptīdu komplekss AA-14, kas satur aminoskābes (Lalanīnu, L-glutamīnskābi, L-asparagīnskābi un L-leicīnu) | otherNutrients ; Peptīdu komplekss AA-14, kas satur aminoskābes (Lalanīnu, L-glutamīnskābi, L-asparagīnskābi un L-leicīnu) ; 0,3 ; mg | Not recognised | Role not identified |
| Peptīdu komplekss AA-3, kas satur aminoskābes (L-lizīnu, L-glutamīnskābi) | otherNutrients ; Peptīdu komplekss AA-3, kas satur aminoskābes (L-lizīnu, L-glutamīnskābi) ; 0,3 ; mg | Not recognised | Role not identified |
| Ūdens | otherIngredients ; Ūdens ; - ; mg | Not recognised | Role not identified |
| Dabisks mentola aromatizētājs | otherIngredients ; Dabisks mentola aromatizētājs ; - ; mg | Not recognised | Role not identified |
| Limonēns, aromatizētājs | otherIngredients ; Limonēns, aromatizētājs ; - ; mg | Not recognised | Role not identified |
| Eigenols, aromatizētājs | otherIngredients ; Eigenols, aromatizētājs ; - ; mg | Not recognised | Role not identified |
| 328 | foodAdditives ; 328 | Not recognised | Role not identified |
| 181 | foodAdditives ; 181 | Not recognised | Role not identified |
| 72 | foodAdditives ; 72 | Not recognised | Role not identified |
| 74 | foodAdditives ; 74 | Not recognised | Role not identified |
| 318 | foodAdditives ; 318 | Not recognised | Role not identified |
| 246 | foodAdditives ; 246 | Not recognised | Role not identified |
Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.
Manufacturer countries
Krievija
French and European references for recognised ingredients
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
Amount read: 0,3 mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
- Information
Amount read: - mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
- Information
Amount read: 24 mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
- Information
Amount read: 2,4 mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
- Information
citrus sinensis is on the list of plants allowed in food supplements (Order of 24 June 2014).
French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
glycyrrhiza glabra is on the list of plants allowed in food supplements (Order of 24 June 2014). Restriction: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
mentha piperita is on the list of plants allowed in food supplements (Order of 24 June 2014).
French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
Amount read: 0,12 mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
- Information
syzygium aromaticum is on the list of plants allowed in food supplements (Order of 24 June 2014).
French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
Amount read: 1,2 mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.
Official source
Internet Archive copy dated 3 May 2025
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Lakrica
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Piparmētra
Read the warning, when it applies and the studies cited
PEPPERMINT - MENTHA X PIPERITA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Essential oil.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Essential oil.
When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.